Globavir to Partner with Fiocruz on Dengue Dx | GenomeWeb

NEW YORK (GenomeWeb) – Globavir today announced a partnership with BioManguinhos, a division of the Oswaldo Cruz Foundation (Fiocruz), to evaluate the firm's PanGlob RT-PCR Dengue diagnostic assay.

Under the terms of the agreement, the partners will work together to evaluate and develop Globavir's PanGlob for commercial launch in Brazil.

Globavir said that the test is more sensitive in detecting Dengue virus from patient samples than other diagnostic assays and can detect it regardless of the virus' specific serotype.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.